Recent Finacing
Recent Raise
ENYO Pharma is a clinical-stage biopharmaceutical company developing oral, selective FXR agonists (Vonafexor, EYP651) for kidney diseases and host-targeting small molecules disrupting viral–human protein interactions.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
